(1)
Abdoli Shadbad, M.; Baghbanzadeh, A.; Baradaran, B. Hsa-MiR-34a-5p Enhances Temozolomide Anti-Tumoral Effects on Glioblastoma: In-Silico and in-Vitro Study. EXCLI J. 2024, 23, 384-400.